Steven Bochnowicz

SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung

David C. Underwood, Ruth R. Osborn, Steven Bochnowicz et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2000 · 297 citations

Asthma, Antifibrotic Therapy, Inflammatory Lung Disease +23

SB 239063, a Potent p38 MAP Kinase Inhibitor, Reduces Inflammatory Cytokine Production, Airways Eosinophil Infiltration, and Persistence

David C. Underwood, Ruth R. Osborn, Charles J. Kotzer et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 244 citations

1,4-Cyclohexanecarboxylates:  Potent and Selective Inhibitors of Phosophodiesterase 4 for the Treatment of Asthma

Siegfried B. Christensen, Aimee M. Guider, Cornelia J. Forster et al. · Journal of Medicinal Chemistry · 1998 · 150 citations · Full text

Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.

David C. Underwood, Charles J. Kotzer, Steven Bochnowicz et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 94 citations

Antiasthmatic Activity of the Second-Generation Phosphodiesterase 4 (PDE4) Inhibitor SB 207499 (Ariflo) in the Guinea Pig

David C. Underwood, Steven Bochnowicz, Ruth R. Osborn et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 70 citations